Literature DB >> 20224044

Leptin: the missing link in Alzheimer disease?

Jenni Harvey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20224044      PMCID： PMC2867030          DOI： 10.1373/clinchem.2010.144006

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents.

Authors:  X-L Li; S Aou; Y Oomura; N Hori; K Fukunaga; T Hori
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

2.  Epidemiological approaches to heart disease: the Framingham Study.

Authors:  T R DAWBER; G F MEADORS; F E MOORE
Journal:  Am J Public Health Nations Health       Date:  1951-03

3.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.

Authors:  Wolfgang Lieb; Alexa S Beiser; Ramachandran S Vasan; Zaldy S Tan; Rhoda Au; Tamara B Harris; Ronenn Roubenoff; Sanford Auerbach; Charles DeCarli; Philip A Wolf; Sudha Seshadri
Journal:  JAMA       Date:  2009-12-16       Impact factor: 56.272

Review 4.  Leptin regulation of neuronal excitability and cognitive function.

Authors:  Jenni Harvey
Journal:  Curr Opin Pharmacol       Date:  2007-11-19       Impact factor: 5.547

5.  Leptin promotes rapid dynamic changes in hippocampal dendritic morphology.

Authors:  Dervla O'Malley; Neil MacDonald; Sarah Mizielinska; Christopher N Connolly; Andrew J Irving; Jenni Harvey
Journal:  Mol Cell Neurosci       Date:  2007-05-10       Impact factor: 4.314
  5 in total
  11 in total

Review 1.  Food for thought: the role of appetitive peptides in age-related cognitive decline.

Authors:  Jim R Fadel; Corinne G Jolivalt; Lawrence P Reagan
Journal:  Ageing Res Rev       Date:  2013-02-13       Impact factor: 10.895

Review 2.  Leptin-mediated ion channel regulation: PI3K pathways, physiological role, and therapeutic potential.

Authors:  Daniela Gavello; Emilio Carbone; Valentina Carabelli
Journal:  Channels (Austin)       Date:  2016-03-28       Impact factor: 2.581

3.  Plasma Leptin Reflects Progression of Neurofibrillary Pathology in Animal Model of Tauopathy.

Authors:  Martin Cente; Stefan Zorad; Tomas Smolek; Lubica Fialova; Natalia Paulenka Ivanovova; Katarina Krskova; Lucia Balazova; Rostislav Skrabana; Peter Filipcik
Journal:  Cell Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.046

4.  Acute leptin treatment enhances functional recovery after spinal cord injury.

Authors:  Carmen María Fernández-Martos; Pau González; Francisco Javier Rodriguez
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

5.  Neuronal models for studying tau pathology.

Authors:  Thorsten Koechling; Filip Lim; Felix Hernandez; Jesus Avila
Journal:  Int J Alzheimers Dis       Date:  2010-07-19

6.  Obesity and the ageing brain: could leptin play a role in neurodegeneration?

Authors:  G H Doherty
Journal:  Curr Gerontol Geriatr Res       Date:  2011-10-16

Review 7.  A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy.

Authors:  Kundlik Gadhave; Deepak Kumar; Vladimir N Uversky; Rajanish Giri
Journal:  Med Res Rev       Date:  2020-08-11       Impact factor: 12.388

8.  Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease.

Authors:  Rachna Agarwal; Puneet Talwar; Suman S Kushwaha; Chandra Bhushan Tripathi; Ritushree Kukreti
Journal:  Ann Indian Acad Neurol       Date:  2015 Jul-Sep       Impact factor: 1.383

9.  The Relation of Circulating Levels of Leptin with Cognition in Patients with Alzheimer's Disease.

Authors:  Mustafa Ülker; Gülay Kenangil
Journal:  Noro Psikiyatr Ars       Date:  2018-06-05       Impact factor: 1.339

10.  Mutant amyloid precursor protein differentially alters adipose biology under obesogenic and non-obesogenic conditions.

Authors:  Linnea R Freeman; Le Zhang; Kalavathi Dasuri; Sun-Ok Fernandez-Kim; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.